Biography delivers deep bio strategy across the full lifecycle—from pipeline and clinical development to commercial launch and portfolio value. AI-native. Expert-led. Evidence- grounded.
Biography delivers strategy across five critical domains for your most important decisions.
Product
Portfolio
Access
Medical
Launch
We partner across the full spectrum of life sciences and health innovation.
We bring deep bio strategy expertise from discovery through commercialization—wherever biology meets innovation.
Therapeutics
Small Molecules, Biologics, Cell & Gene
Medical Device
Surgical Robotics, Implantable Devices
Diagnostics
Companion Diagnostics, Multi-Omics
TechBio
AI-Driven Biology, Computational Drug Discovery
MedTech
Drug-Device, 3D Bioprinting
Digital Health
Digital Therapeutics, Remote Monitoring
From first clinical evidence through commercial launch, Biography deploys AutoBio to deliver deep bio strategy at every critical moment— expert-validated intelligence, grounded in data, from biology to belief.
Product
We help shape winning products and maximize their commercial value across the full lifecycle—from early asset strategy and indication prioritization through launch positioning and lifecycle management. AutoBio surfaces the commercial signal; our experts build the strategy.
Core Capabilities
01
Asset Strategy & Indication Prioritization
02
Target Product Profile (TPP) & Winning Label Development
03
Commercial Positioning & Messaging Architecture
04
Market Assessment & Revenue Forecasting
05
Go-to-Market & Customer Engagement Strategy
06
Lifecycle & Franchise Strategy
Portfolio
We help biopharma companies optimize the value of their product portfolios—prioritizing assets, defining therapeutic area strategy, and identifying the BD and licensing opportunities that accelerate growth. AutoBio maps the landscape; our experts set the priorities.
Core Capabilities
01
Portfolio Strategy & Asset Prioritization
02
Therapeutic Area & Franchise Strategy
03
Pipeline Opportunity Assessment
04
Portfolio Valuation & Forecasting
05
Business Development & Licensing Strategy
06
Asset Screening & Due Diligence Support
Medical
We build the evidence strategy and medical affairs framework that shapes clinical belief—aligning publication planning, congress strategy, and KOL engagement into a coherent scientific narrative that supports launch and sustains credibility through the lifecycle. AutoBio tracks the evidence; our experts build the scientific narrative.
Core Capabilities
01
Medical Affairs Strategy
02
Integrated Evidence & Publication Strategy
03
KOL Identification, Mapping & Engagement Strategy
04
Congress & Scientific Exchange Strategy
05
Competitive Scientific Intelligence
06
HEOR & Real-World Evidence Strategy
Access
We optimize pricing and access strategy through the close integration of product goals, payer dynamics, and market-specific evidence requirements—delivering the frameworks that ensure your product reaches patients and sustains commercial value. AutoBio models the payer dynamics; our experts build the access strategy.
Core Capabilities
01
U.S. & Global Payer Landscape Assessment
02
Launch Pricing Strategy
03
Payer Value Proposition & Dossier Strategy
04
Market Access & Reimbursement Strategy
05
Contracting & Innovative Pricing Strategy
06
Access Due Diligence & Assumption Pressure Testing
Launch
Launch is complex, fast-paced, and high-stakes. We integrate commercial, medical, and access strategy into a single coordinated go-to-market plan—aligning every workstream, stakeholder, and milestone on the critical path to market. AutoBio integrates the intelligence; our experts lead the execution.
Core Capabilities
01
Launch Situation Analysis
02
Integrated Launch Strategy
03
Organizational & Commercial Readiness
04
Stakeholder Engagement & Market Development Strategy
05
Global Launch Sequencing & Go-to-Market
06
Post-Launch Strategy & Optimization
Emerging Biotech Solutions
See how we tailor these capabilities for early-stage life sciences teams
Biography brings deep bio strategy depth across today's most consequential therapeutic frontiers —where innovation moves fastest, the stakes are highest, and every decision demands expert intelligence at platform speed.
From first-in-class breakthroughs to competitive entrants and late-stage blockbusters, we bring clarity, conviction, and strategic precision to every stage of development and commercialization.
THERAPEUTIC EXPERTISE
Therapeutic Expertise
Gene Therapy
Cell Therapy
Regenerative Medicine
RNA / DNA-based Therapies
Targeted Biologics
Antibody-Drug Conjugates
mRNA Therapeutics
Gene Editing
Kinase Inhibitors
Monoclonal Antibodies
Bispecific T-cell Engagers
Immune Checkpoint Inhibitors
We work at the leading edge of life sciences modalities—bringing deep bio strategy and expert intelligence to the frontiers reshaping the future of medicine.
Every Biography engagement follows a rigorous process—expert strategy, platform intelligence, mission-critical delivery.
Process
Discover
01
We connect your clinical data, competitive intelligence, and strategic priorities—integrating therapeutic area requirements, regulatory frameworks, and stakeholder landscapes to define the strategic foundation.
Analyze
02
AutoBio's proprietary apps and workflows generate competitive intelligence, market access analysis, medical affairs strategy, and launch-critical insights with pharmaceutical-grade accuracy.
Build
03
Biography strategists refine and customize platform intelligence for your specific strategic context—shaping competitive positioning, tailoring frameworks for stakeholder audiences, and ensuring every deliverable is mission-critical ready.
Validate
04
Our expert strategists validate every output for regulatory compliance, scientific accuracy, and competitive positioning—ensuring the mission-critical reliability Deep Bio strategy demands.
